Drug intelligence / Profile preview

albumin + electrolyte solution

Development stage
Unknown
Lead developer
PGIMER Chandigarh
Modality
Small Molecules
Administration
Intravenous
01

Overview

Albumin + electrolyte solution refers to a fluid resuscitation regimen being evaluated for the treatment of sepsis-induced hypotension in patients with cirrhosis and acute-on-chronic liver failure (ACLF). This intervention, specifically studied at the Post Graduate Institute of Medical Education and Research, Chandigarh, involves the administration of 20% human albumin (at doses of 0.5-1 g/kg) in conjunction with balanced salt solutions (such as Plasmalyte). Albumin acts as a colloid to increase plasma oncotic pressure and expand intravascular volume, while the electrolyte solution provides crystalloid-based volume replacement and maintains acid-base balance. The regimen aims to improve hemodynamic stability and fluid responsiveness in critically ill liver disease patients, who often exhibit baseline hypoalbuminemia and altered hemodynamics.

Other names
20% albumin and balanced salt solutionalbumin and plasmalytealbumin + electrolyte solution-Post Graduate Institute of Medical Education and Research, Chandigarh-sepsis-induced hypotension-cirrhosis-acute-on-chronic liver failure

Beyond the preview

Go deeper on albumin + electrolyte solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albumin + electrolyte solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call